Vivos Therapeutics Inc.

NASDAQ: VVOS · Real-Time Price · USD
4.42
-0.08 (-1.78%)
At close: Aug 19, 2025, 10:27 AM

Vivos Therapeutics Revenue

Vivos Therapeutics reported an annual revenue of $15.03M, reflecting a 8.91% growth. For the quarter ending March 31, 2025, Vivos Therapeutics generated $3.02M in revenue.
Revenue (ttm)
15.03M
Revenue Growth
8.91%
Price / Sales Ratio
1.43
Revenue / Employee
137.9K
Employees
109
Market Cap
26.03M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 15.03M +8.91%
Dec 31, 2023 13.8M -13.87%
Dec 31, 2022 16.02M -5.10%
Dec 31, 2021 16.89M +29.23%
Dec 31, 2020 13.07M +14.68%
Dec 31, 2019 11.39M +200.43%
Dec 31, 2018 3.79M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.